Chugai Pharmaceutical Co., Ltd. (CHGCY)
21.82
-0.37
(-1.67%)
USD |
OTCM |
Aug 24, 16:00
Chugai Pharmaceutical Net Income (Quarterly) : 730.02M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 730.02M |
| March 31, 2026 | 735.63M |
| December 31, 2025 | 833.45M |
| September 30, 2025 | 754.36M |
| June 30, 2025 | 672.03M |
| March 31, 2025 | 638.00M |
| December 31, 2024 | 600.85M |
| September 30, 2024 | 733.71M |
| June 30, 2024 | 717.84M |
| March 31, 2024 | 501.09M |
| December 31, 2023 | 616.68M |
| September 30, 2023 | 536.61M |
| June 30, 2023 | 604.89M |
| March 31, 2023 | 555.15M |
| December 31, 2022 | 724.66M |
| September 30, 2022 | 490.11M |
| June 30, 2022 | 557.45M |
| March 31, 2022 | 1.133B |
| December 31, 2021 | 869.13M |
| September 30, 2021 | 781.38M |
| June 30, 2021 | 646.50M |
| March 31, 2021 | 446.85M |
| December 31, 2020 | 500.62M |
| September 30, 2020 | 566.54M |
| June 30, 2020 | 472.06M |
| Date | Value |
|---|---|
| March 31, 2020 | 472.88M |
| December 31, 2019 | 369.47M |
| September 30, 2019 | 448.50M |
| June 30, 2019 | 311.35M |
| March 31, 2019 | 318.04M |
| December 31, 2018 | 196.92M |
| September 30, 2018 | 195.78M |
| June 30, 2018 | 191.41M |
| March 31, 2018 | 259.96M |
| December 31, 2017 | 138.98M |
| September 30, 2017 | 192.11M |
| June 30, 2017 | 160.24M |
| March 31, 2017 | 164.89M |
| December 31, 2016 | 97.44M |
| September 30, 2016 | 114.13M |
| June 30, 2016 | 160.55M |
| March 31, 2016 | 127.58M |
| December 31, 2015 | 113.71M |
| September 30, 2015 | 146.22M |
| June 30, 2015 | 131.01M |
| March 31, 2015 | 124.63M |
| December 31, 2014 | 98.46M |
| September 30, 2014 | 105.81M |
| June 30, 2014 | 101.69M |
| March 31, 2014 | 186.41M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 710.72M |
| Daiichi Sankyo Co., Ltd. | 430.72M |
| Eisai Co., Ltd. | 120.18M |
| Santen Pharmaceutical Co., Ltd. | 45.18M |
| Ono Pharmaceutical Co., Ltd. | 151.63M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 2.144B |
| Total Expenses (Quarterly) | 1.414B |
| EPS Diluted (Quarterly) | 0.2218 |
| Enterprise Value | 65.99B |
| Gross Profit Margin (Quarterly) | 69.49% |
| Profit Margin (Quarterly) | 34.06% |
| Earnings Yield | 4.25% |
| Operating Earnings Yield | 6.11% |
| Normalized Earnings Yield | 4.453 |